PRMSX
Price
$33.90
Change
-$0.54 (-1.57%)
Updated
Sep 6 closing price
VEIEX
Price
$27.63
Change
-$0.39 (-1.39%)
Updated
Sep 6 closing price
Ad is loading...

PRMSX vs VEIEX

Header iconPRMSX vs VEIEX Comparison
Open Charts PRMSX vs VEIEXBanner chart's image
T. Rowe Price Emerging Markets Stock
Price$33.90
Change-$0.54 (-1.57%)
VolumeN/A
CapitalizationN/A
Vanguard Emerging Mkts Stock Idx I
Price$27.63
Change-$0.39 (-1.39%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PRMSX vs VEIEX Comparison Chart
Loading...
VS
PRMSX vs. VEIEX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRMSX is a Buy and VEIEX is a Buy.

FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 108B vs. PRMSX (4.95B). VEIEX pays higher dividends than PRMSX: VEIEX (3.27) vs PRMSX (1.09). PRMSX was incepted earlier than VEIEX: PRMSX (29 years) vs VEIEX (30 years). PRMSX is a more actively managed with annual turnover of: 47.60 vs. VEIEX (5.00). VEIEX has a lower initial minimum investment than PRMSX: VEIEX (0) vs PRMSX (2500). VEIEX annual gain was more profitable for investors over the last year : 11.44 vs. PRMSX (1.52). VEIEX return over 5 years is better than : 16.99 vs. PRMSX (-16.02).
PRMSXVEIEXPRMSX / VEIEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years30 years-
Gain YTD-0.5497.877-7%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.95B108B5%
Annual Yield % from dividends1.093.2733%
Returns for 1 year1.5211.4413%
Returns for 3 years-34.67-10.67325%
Returns for 5 years-16.0216.99-94%
Returns for 10 years0.4612.904%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATS25.550.42
+1.67%
ATS Corp
VRSN183.56-1.33
-0.72%
VeriSign
AMTB20.98-0.24
-1.13%
Amerant Bancorp
TLYS4.75-0.19
-3.85%
Tilly's
MIRA1.58-0.12
-7.06%
MIRA Pharmaceuticals